Physician profile
David M Heller
NPI 1639274251
$3,334.29
in general payments reported to CMS, 2019-2025
34 companies · $742 in 2025
The $742 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $192 · 2022: $207 · 2023: $314 · 2024: $808 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $668.69 | 2019-2025 | Evenity, Repatha, Repatha |
| Abbvie INC. | $391.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $280.14 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $200.61 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $199.42 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $192.26 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Lilly USA, LLC | $162.21 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $157.86 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Daiichi Sankyo INC. | $127.35 | 2019-2025 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $112.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $105.48 | 2019 | |
| Horizon Therapeutics Plc | $70.78 | 2019-2020 | |
| Astellas Pharma US INC | $70.51 | 2019-2024 | Veozah |
| Exact Sciences Corporation | $61.35 | 2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $52.69 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41.18 | 2024-2025 | Symplicity G3 |
| Sanofi-Aventis U.S. LLC | $40.74 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.98 | 2022 | |
| Tersera Therapeutics LLC | $33.21 | 2024 | Quzyttir |
| Inspire Medical Systems, INC. | $32.94 | 2024 | Inspire |
| Dexcom, INC. | $29.36 | 2025 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $24.94 | 2025 | |
| Teleflex LLC | $24.65 | 2024 | Urolift |
| Phathom Pharmaceuticals, INC. | $24.37 | 2024 | Voquezna |
| Hologic Sales and Service, LLC | $24.09 | 2024 | Aptima |
| Sanofi Pasteur INC. | $24.05 | 2025 | |
| Biogen, INC. | $22.38 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.24 | 2019 | |
| Eisai INC. | $20.65 | 2023 | |
| Abbott Laboratories | $18.81 | 2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $16.66 | 2022 | |
| Irhythm Technologies, INC. | $16.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $14.48 | 2019 | |
| Duchesnay USA Incorporated | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.